|
---|
Category:Legal-Exhibit
MONTHYEARML16021A1952015-12-29029 December 2015 Official Exhibit - NRC-002-R-MA-CM01 - Shine Medical Technologies, Inc., Medical Isotope Production Facility Draft Construction Permit ML16021A1942015-12-29029 December 2015 Official Exhibit - NRC-014-MA-CM01 - NRC Staff Responses to Post-Hearing Questions ML16021A1932015-12-22022 December 2015 Official Exhibit - SHN-030-MA-CM01 - Shine Response to Commission Post Hearing Questions ML15351A2812015-12-15015 December 2015 Official Exhibit - SHN-026-MA-CM01 - Shine Overview Panel Presentation ML15351A2822015-12-15015 December 2015 Official Exhibit - SHN-027-MA-CM01 - Shine Presentation Slides: Safety Panel 1 ML15351A2842015-12-15015 December 2015 Official Exhibit - SHN-028-MA-CM01 - Shine Presentation Slides: Safety Panel 2 ML15351A2512015-12-11011 December 2015 Official Exhibit - NRC-012-R-MA-CM01 - Staff Presentation Slides - Safety Panel 2 (December 8, 2015, Corrected Exhibit Filed December 11, 2015) ML15351A2492015-12-0808 December 2015 Official Exhibit - NRC-006R-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application - Environmental Report, (PSAR) Chapter 19, Figure 19.5.2-6 Through Figure 19.5.2-9 (August 27, 2015) ML15351A2242015-12-0808 December 2015 Official Exhibit - NRC-004-R-MA-CM01 - NRC Staff Responses to Commission Pre-Hearing Questions, (Originally Filed on November 24, 2015), (Revised December 8, 2015) ML15351A2372015-12-0808 December 2015 Official Exhibit - NRC-006L-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application - Environmental Report, (PSAR) Chapter 19, Figure 19.3.2-1 Through Figure 19.3.2-36 (August 27, 2015) ML15351A2302015-12-0808 December 2015 Official Exhibit - NRC-008-MA-CM01 - Safety Evaluation Report Related to Shine Medical Technologies, Inc. Construction Permit Application for a Medial Radioisotope Production Facility, (Revised December 8, 2015) ML15351A2272015-12-0808 December 2015 Official Exhibit - NRC-002-MA-CM01 - Draft Construction Permit for Shine Medical Technologies, Inc. (December 8, 2015) ML15351A2532015-12-0808 December 2015 Official Exhibit - SHN-002-MA-CM01 - Shine Medical Technologies, Inc.'S Responses to Commission'S Public Pre-Hearing Questions ML15351A2552015-12-0808 December 2015 Official Exhibit - SHN-004-MA-CM01 - Statement of Qualifications of Joseph M. Aldieri ML15351A2562015-12-0808 December 2015 Official Exhibit - SHN-005-MA-CM01 - Statement of Qualifications of Jeffrey M. Bartelme ML15351A2572015-12-0808 December 2015 Official Exhibit - SHN-014-MA-CM01 - Statement of Qualifications of James W. Mcintyre ML15351A2582015-12-0808 December 2015 Official Exhibit - SHN-015-MA-CM01 - Statement of Qualifications of John B. Mclean ML15351A2592015-12-0808 December 2015 Official Exhibit - SHN-016-MA-CM01 - Statement of Qualifications of William D. Newmyer ML15351A2602015-12-0808 December 2015 Official Exhibit - SHN-017-MA-CM01 - Statement of Qualifications of Greg Piefer ML15351A2622015-12-0808 December 2015 Official Exhibit - SHN-018-MA-CM01 - Statement of Qualifications of Katrina M. Pitas ML15351A2632015-12-0808 December 2015 Official Exhibit - SHN-019-MA-CM01 - Statement of Qualifications of Erwin T. Prater ML15351A2642015-12-0808 December 2015 Official Exhibit - SHN-020-MA-CM01 - Statement of Qualifications of Louis Restrepo ML15351A2652015-12-0808 December 2015 Official Exhibit - SHN-021-MA-CM01 - Statement of Qualifications of Eric N. Van Abel ML15351A2782015-12-0808 December 2015 Official Exhibit - SHN-011-MA-CM01 - Statement of Qualifications of Timothy P. Krause ML15351A2912015-12-0808 December 2015 Official Exhibit - NRC-010-MA-CM01 - Staff Presentation Slides - Overview (December 8, 2015) ML15351A2922015-12-0808 December 2015 Official Exhibit - NRC-011-MA-CM01 - Staff Presentation Slides - Safety Panel 1( December 8, 2015) ML15351A2932015-12-0808 December 2015 Official Exhibit - NRC-013-MA-CM01 - Staff Presentation Slides - Environmental Panel (December 8, 2015) ML15351A2852015-12-0808 December 2015 Official Exhibit - SHN-029-MA-CM01 - Shine Presentation Slides: Environmental Panel ML15351A2662015-12-0808 December 2015 Official Exhibit - SHN-022-MA-CM01 - Statement of Qualifications of George F. Vandergrift ML15351A2802015-12-0808 December 2015 Official Exhibit - SHN-013-MA-CM01 - Statement of Qualifications of C. Michael Launi ML15351A2792015-12-0808 December 2015 Official Exhibit - SHN-012-MA-CM01 - Statement of Qualifications of Thomas Krzewinski ML15351A2772015-12-0808 December 2015 Official Exhibit - SHN-010-MA-CM01 - Statement of Qualifications of Catherine Kolb ML15351A2752015-12-0808 December 2015 Official Exhibit - SHN-009-MA-CM01 - Statement of Qualifications of Alan Hull ML15351A2742015-12-0808 December 2015 Official Exhibit - SHN-008-MA-CM01 - Statement of Qualifications of William Hennessy ML15351A2732015-12-0808 December 2015 Official Exhibit - SHN-007-MA-CM01 - Statement of Qualifications of James Costedio ML15351A2722015-12-0808 December 2015 Official Exhibit - SHN-025-MA-CM01 - Statement of Qualifications of Steven L. Zander ML15351A2712015-12-0808 December 2015 Official Exhibit - SHN-024-MA-CM01 - Statement of Qualifications of Ernest Wright ML15351A2702015-12-0808 December 2015 Official Exhibit - SHN-006-MA-CM01 - Statement of Qualifications of Richard Vann Bynum ML15351A2692015-12-0808 December 2015 Official Exhibit - SHN-023-MA-CM01 - Statement of Qualifications of Tamela B. Wheeler ML15351A2522015-11-24024 November 2015 Official Exhibit - SHN-001-MA-CM01 - Applicant'S Pre-Filed Testimony of James Costedio for the Mandatory Hearing on Uncontested Issues for the Shine Medical Technologies, Inc. Medical Radioisotope Production Facility ML15351A2282015-11-17017 November 2015 Official Exhibit - NRC-003-MA-CM01 - Draft Record of Decision for Shine Medical Technologies, Inc. Construction Permit Application (November 17, 2015) ML15351A2312015-10-31031 October 2015 Official Exhibit - NRC-009-MA-CM01 - NUREG-2183, Final Environmental Impact Statement for the Construction Permit for the Shine Medical Radioisotope Production Facility (October 16, 2015) ML15351A2262015-10-22022 October 2015 Official Exhibit - NRC-001-MA-CM01 - SECY-15-0130, Staff Statement in Support of the Uncontested Hearing for Issuance of Construction Permit for the Shine Medical Technologies, Inc. Medical Radioisotope Production Facility (October 22, 2015 ML15351A2412015-09-16016 September 2015 Official Exhibit - NRC-006B-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application - Updated General Information (September 16, 2015) ML15351A2442015-08-27027 August 2015 Official Exhibit - NRC-006E-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application, (Psar), Chapter 2, Figure 2.5-1 Through Figure 2.5-6 (August 27, 2015) ML15351A2432015-08-27027 August 2015 Official Exhibit - NRC-006D-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application - (Psar), Chapter 2, Figure 2.4-1 Through Figure 2.4-11 (August 27, 2015) ML15351A2452015-08-27027 August 2015 Official Exhibit - NRC-006N-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application - Environmental Report, Chapter 19 Figure 19.3.4-1 to Chapter 19 Figure 19.3.4-8 (August 27, 2015) ML15351A2392015-08-27027 August 2015 Official Exhibit - NRC-006M-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application - Environmental Report, (PSAR) Chapter 19, Figure 19.3.3-1 Through Figure 19.3.3-7 (August 27, 2015) ML15351A2462015-08-27027 August 2015 Official Exhibit - NRC-006O-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application, Environmental Report, (PSAR) Chapter 19 Figure 19.3.5-1 Through Figure 19.3.8-2 (August 27, 2015) ML15351A2352015-08-27027 August 2015 Official Exhibit - NRC-006K-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application - Environmental Report, (PSAR) Chapter 19 Figure 19.3.1-7 Through Figure 19.3.1-9 (August 27, 2015) 2015-09-16
[Table view] |
Text
United States Nuclear Regulatory Commission Official Hearing Exhibit In the Matter of: SHINE MEDICAL TECHNOLOGIES, INC.
(Medical Radioisotope Production Facility)
Commission Mandatory Hearing Docket #: 05000608 Exhibit #: SHN-028-MA-CM01 Identified: 12/15/2015 Admitted: 12/15/2015 Withdrawn:
Rejected: Stricken:
Other: Exhibit SHN-028 Commission Mandatory Hearing SHINE Construction Permit Application S f Safety - Panel P l2 Accident Analysis December 15,, 2015
Accident Initiating Events and Scenarios Bases for identification of accidents:
Hazard and Operability Study (HAZOPS)
Preliminary Hazard Analysis (PHA)
List of events from NUREG NUREG-15371537 and the Interim Staff Guidance (ISG) augmenting NUREG-1537 Experience of the hazards analysis team Current preliminary design information Qualitative evaluations within categories Quantitative evaluations to determine consequences Postulated P t l t d an irradiation i di ti ffacility ilit (IF) and d radioisotope di i t production d ti facility (RPF) Maximum Hypothetical Accident (MHA)
Establishes an outer limit consequence, bounds other accidents Most limiting MHA was in the RPF (Facility MHA) 2
IF Postulated Maximum Hypothetical Accident Target solution vessel (TSV) and subcritical b iti l assembly bl supportt structure (SASS) integrity lost, Subcritical Assembly target solution spills into Support Structure irradiation unit (IU) cell (SASS)
Maximum inventories assumed in TSV TSV (Internal to Pool presence ignored SASS)
High radiation detected detected, initiates alarms and confinement High efficiency particulate air (HEPA) filters and charcoal adsorbers d b credited dit d Dose consequences Worker TEDE: 3.1 rem TSV Dump Tank Public (site boundary) TEDE:
0.017 rem 3
RPF Maximum Hypothetical Accident (Facility MHA)
The five noble g gas TSV Off Gas storage tanks rupture Purge simultaneously NGRS Compressors With the maximum inventory y Contents are instantly Noble Gas released Storage Tanks Al RAD Al RAD Al RAD Al RAD Al RAD g radiation levels initiate High alarm and cell isolation Redundant isolation dampers close Condensate Al RAD 10% of the activity bypasses Knock Out Tank Process Vessel Vent System the isolation dampers 10% of the activity leaks Radioactive through penetrations Liquid Waste 4
RPF Maximum Hypothetical Accident (Facility MHA)
Dose consequences Worker TEDE: 3.6 rem Public (site boundary) TEDE: 0.082 rem The MHA consequences are conservative Simultaneous, instantaneous rupture Entirety of noble gas is transferred and released The five tanks are filled to capacity Additional ventilation isolation dampers would close, but are not credited Actual doses would be lower Radiological consequences to workers and the public are within the limits of 10 CFR 20.1101, 20.1201,, and 20.1301 5
United States Nuclear Regulatory Commission Official Hearing Exhibit In the Matter of: SHINE MEDICAL TECHNOLOGIES, INC.
(Medical Radioisotope Production Facility)
Commission Mandatory Hearing Docket #: 05000608 Exhibit #: SHN-028-MA-CM01 Identified: 12/15/2015 Admitted: 12/15/2015 Withdrawn:
Rejected: Stricken:
Other: Exhibit SHN-028 Commission Mandatory Hearing SHINE Construction Permit Application S f Safety - Panel P l2 Accident Analysis December 15,, 2015
Accident Initiating Events and Scenarios Bases for identification of accidents:
Hazard and Operability Study (HAZOPS)
Preliminary Hazard Analysis (PHA)
List of events from NUREG NUREG-15371537 and the Interim Staff Guidance (ISG) augmenting NUREG-1537 Experience of the hazards analysis team Current preliminary design information Qualitative evaluations within categories Quantitative evaluations to determine consequences Postulated P t l t d an irradiation i di ti ffacility ilit (IF) and d radioisotope di i t production d ti facility (RPF) Maximum Hypothetical Accident (MHA)
Establishes an outer limit consequence, bounds other accidents Most limiting MHA was in the RPF (Facility MHA) 2
IF Postulated Maximum Hypothetical Accident Target solution vessel (TSV) and subcritical b iti l assembly bl supportt structure (SASS) integrity lost, Subcritical Assembly target solution spills into Support Structure irradiation unit (IU) cell (SASS)
Maximum inventories assumed in TSV TSV (Internal to Pool presence ignored SASS)
High radiation detected detected, initiates alarms and confinement High efficiency particulate air (HEPA) filters and charcoal adsorbers d b credited dit d Dose consequences Worker TEDE: 3.1 rem TSV Dump Tank Public (site boundary) TEDE:
0.017 rem 3
RPF Maximum Hypothetical Accident (Facility MHA)
The five noble g gas TSV Off Gas storage tanks rupture Purge simultaneously NGRS Compressors With the maximum inventory y Contents are instantly Noble Gas released Storage Tanks Al RAD Al RAD Al RAD Al RAD Al RAD g radiation levels initiate High alarm and cell isolation Redundant isolation dampers close Condensate Al RAD 10% of the activity bypasses Knock Out Tank Process Vessel Vent System the isolation dampers 10% of the activity leaks Radioactive through penetrations Liquid Waste 4
RPF Maximum Hypothetical Accident (Facility MHA)
Dose consequences Worker TEDE: 3.6 rem Public (site boundary) TEDE: 0.082 rem The MHA consequences are conservative Simultaneous, instantaneous rupture Entirety of noble gas is transferred and released The five tanks are filled to capacity Additional ventilation isolation dampers would close, but are not credited Actual doses would be lower Radiological consequences to workers and the public are within the limits of 10 CFR 20.1101, 20.1201,, and 20.1301 5